We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+5.95%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$7.75B
AUM Growth
+$180M
(+2.4%)
Cap. Flow
-$55.1M
Cap. Flow
% of AUM
-0.71%
Top 10 Holdings %
Top 10 Hldgs %
15.53%
Holding
560
New
192
Increased
91
Reduced
96
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$122M |
| 2 |
L3Harris
LHX
|
+$117M |
| 3 |
General Dynamics
GD
|
+$110M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$103M |
| 5 |
NXP Semiconductors
NXPI
|
+$91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$143M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$111M |
| 3 |
Skyworks Solutions
SWKS
|
+$109M |
| 4 |
Lowe's Companies
LOW
|
+$93.7M |
| 5 |
Emerson Electric
EMR
|
+$88.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.47% |
| 2 | Industrials | 15.13% |
| 3 | Healthcare | 14.64% |
| 4 | Financials | 8.83% |
| 5 | Consumer Discretionary | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Guardant Health
GH
$22.6B
| $2.37M | 0.03% |
27,399
-25,111
| -48% | -$1.92M |
|
|
KIN
302
DELISTED
Kindred Biosciences, Inc.
KIN
| $2.37M | 0.03% |
283,942
-126,270
| -31% | -$1.09M |
|
303
Zai Lab
ZLAB
$2.62B
| $2.32M | 0.03% |
+66,607
| New | +$1.96M |
|
|
MOR
304
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $2.31M | 0.03% |
95,490
+19,268
| +25% | +$478K |
|
305
Alector
ALEC
$199M
| $2.29M | 0.03% |
120,292
-2,591
| -2% | -$52.6K |
|
306
Applied Materials
AMAT
$428B
| $2.27M | 0.03% |
+50,589
| New | +$2.13M |
|
307
ADMA Biologics
ADMA
$2.22B
| $2.27M | 0.03% |
+585,265
| New | +$2.58M |
|
|
MDSO
308
DELISTED
Medidata Solutions, Inc.
MDSO
| $2.26M | 0.03% |
+25,000
| New | +$2.19M |
|
309
Gossamer Bio
GOSS
$87M
| $2.26M | 0.03% |
101,864
-50,619
| -33% | -$968K |
|
310
Fiverr
FVRR
$339M
| $2.25M | 0.03% |
+75,662
| New | +$2.31M |
|
311
Mondelez International
MDLZ
$79.9B
| $2.25M | 0.03% |
+41,683
| New | +$2.16M |
|
312
KALA BIO
KALA
$14.5M
| $2.23M | 0.03% |
140
+77
| +122% | +$1.28M |
|
|
ZSAN
313
DELISTED
Zosano Pharma Corporation
ZSAN
| $2.16M | 0.03% |
+18,893
| New | +$2.24M |
|
|
CVET
314
DELISTED
Covetrus, Inc. Common Stock
CVET
| $2.15M | 0.03% |
+88,102
| New | +$2.54M |
|
315
Fortune Brands Innovations
FBIN
$6.06B
| $2.15M | 0.03% |
+43,993
| New | +$1.96M |
|
|
TWOU
316
DELISTED
2U Inc
TWOU
| $2.12M | 0.03% |
+1,881
| New | +$2.77M |
|
|
CARM
317
CALL
DELISTED
Carisma Therapeutics
CARM
| $2.1M | 0.03% |
+70,000
| New | +$2.1M |
|
318
CALL
HighPeak Energy
HPK
$910M
| $2.03M | 0.03% |
200,000
| – | – |
|
319
Archer Daniels Midland
ADM
$36.9B
| $2M | 0.03% |
+48,946
| New | +$2.03M |
|
320
SI-BONE Inc
SIBN
$834M
| $1.99M | 0.03% |
+97,890
| New | +$1.68M |
|
321
Scholar Rock
SRRK
$6.44B
| $1.92M | 0.02% |
+121,309
| New | +$2.25M |
|
322
CALL
Clarivate
CLVT
$1.16B
| $1.92M | 0.02% |
125,001
| – | – |
|
323
Amneal Pharmaceuticals
AMRX
$5.79B
| $1.92M | 0.02% |
267,475
-127,881
| -32% | -$1.31M |
|
|
CALA
324
DELISTED
Calithera Biosciences, Inc
CALA
| $1.92M | 0.02% |
+24,564
| New | +$2.79M |
|
|
VLRX
325
CALL
DELISTED
VALERITAS HOLDINGS INC
VLRX
| $1.82M | 0.02% |
693,477
-2
| -0% | -$10 |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2019 Portfolio in Review
As of Q2 2019, Alyeska Investment Group held 560 positions worth $7.75B, up 2.4% from $7.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Alyeska Investment Group's Q2 2019 filing shows 192 new, 91 increased, 96 reduced and 133 closed positions. Its largest new stake was Uber: 2,870,924 shares worth $133M. The largest sale was Intel, an estimated $143M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.
- Alyeska Investment Group's largest Q2 2019 buy was Uber: 2,870,924 shares worth $133M.
- Alyeska Investment Group added most to NXP Semiconductors in Q2 2019, an estimated $91M increase.
- Alyeska Investment Group's biggest Q2 2019 reduction was Activision Blizzard, cutting an estimated $64.8M.
- Alyeska Investment Group fully exited Intel in Q2 2019, selling an estimated $143M.
- Alyeska Investment Group's ten largest holdings make up 16% of its $7.75B portfolio in Q2 2019.
- Alyeska Investment Group opened 192 new positions and closed 133 in Q2 2019.
- Alyeska Investment Group's portfolio value rose 2.4% quarter-over-quarter to $7.75B.
Based on Alyeska Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.